MOLECULAR PARTNERS AG (MLLCF)
Clinical trial NCT06369220: enrollment: 344 → 331 participants.
Clinical trial NCT06369220: enrollment: 344 → 331 participants.
Clinical trial NCT06978660 updates: 1. completion date: 2026-05-01 → 2026-12-31 2. primary completion date: 2026-05-01 → 2026-09-30 3. enrollment: 2000 → 2200 participants
Clinical trial NCT05009992: collaborators added: Tough2gether Foundation.
Clinical trial NCT05303467 updates: 1. completion date: 2027-01-31 → 2027-04-30 2. primary completion date: 2026-07-31 → 2026-10-31
Clinical trial NCT07613307: start date: 2026-05-01 → 2026-07-01.
Clinical trial NCT05555732: completion date: 2029-05-11 → 2031-05-11.
Clinical trial NCT05323955 updates: 1. completion date: 2026-07-01 → 2027-11-01 2. primary completion date: 2026-04-01 → 2026-11-01
Clinical trial NCT07516184 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-30 → 2026-06-10
Clinical trial NCT07432633: start date: 2026-03-18 → 2026-02-19.
Clinical trial NCT06151964 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 160 → 166 participants 3. enrollment type: ESTIMATED → ACTUAL